Thomas W P Friedl (Thomas Friedl)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Breast cancer research : BCR

British journal of cancer

Journal of clinical medicine

Cancers

University Hospital Ulm

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Ulm

Germany

Statistician :: Gynecology & Obstetrics

Publications

Stefan Lukac, Thomas W P Friedl, Tobias Gruber, Marinus Schmid, Elena Leinert, Wolfgang Janni, Katharina Hancke, Davut Dayan
Changes in Endometriosis-Associated Symptoms Following Immunization against SARS-CoV-2: A Cross-Sectional Study. Journal of clinical medicine 13 (5) (2024)
Robin Wenzel, Arkadius Polasik, Thomas W P Friedl, Steffen Walter, Wolfgang Janni, Ulrike Friebe-Hoffmann
Out of pocket health-care services in Germany during pregnancy under consideration of migration and acculturation. Archives of gynecology and obstetrics (2024)
Stefan Lukac, Thomas W P Friedl, Tobias Gruber, Marinus Schmid, Elena Leinert, Wolfgang Janni, Katharina Hancke, Davut Dayan
Changes in Endometriosis-Associated Symptoms Following Immunization against SARS-CoV-2: A Cross-Sectional Study. Journal of clinical medicine 13 (5) (2024)
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian K Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W P Friedl
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast cancer research : BCR 25 (1) (2023)
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian K Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W P Friedl
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast cancer research : BCR 25 (1) (2023)
Andre Franken, Annika Kraemer, Alicia Sicking, Meike Watolla, Mahdi Rivandi, Liwen Yang, Jens Warfsmann, Bernhard M Polzer, Thomas W P Friedl, Franziska Meier-Stiegen, Nikolas H Stoecklein, Davut Dayan, Sabine Riethdorf, Volkmar Mueller, Klaus Pantel, André Koch, Andreas D Hartkopf, Natalia Krawczyk, Eugen Ruckhaeberle, Dieter Niederacher, Tanja Fehm, Tanja N Fehm
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value. British journal of cancer (2023)
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian K Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W P Friedl
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast cancer research : BCR 25 (1) (2023)
Andre Franken, Annika Kraemer, Alicia Sicking, Meike Watolla, Mahdi Rivandi, Liwen Yang, Jens Warfsmann, Bernhard M Polzer, Thomas W P Friedl, Franziska Meier-Stiegen, Nikolas H Stoecklein, Davut Dayan, Sabine Riethdorf, Volkmar Mueller, Klaus Pantel, André Koch, Andreas D Hartkopf, Natalia Krawczyk, Eugen Ruckhaeberle, Dieter Niederacher, Tanja Fehm, Tanja N Fehm
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value. British journal of cancer (2023)
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian K Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W P Friedl
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast cancer research : BCR 25 (1) (2023)
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian K Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W P Friedl
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast cancer research : BCR 25 (1) (2023)
Elisabeth K Trapp, Peter Andreas Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller, Nadia Harbeck, Ralf Lorenz, Claudia Schumacher, Georg Heinrich, Fabienne Schochter, Amelie de Gregorio, Marie Tzschaschel, Brigitte Rack, Wolfgang Janni, Thomas W P Friedl
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial. Cancers 14 (16) (2022)
Amelie de Gregorio, Wolfgang Janni, Thomas W P Friedl, Ulrike Nitz, Brigitte Rack, Andreas Schneeweiss, Ronald Kates, Tanja Fehm, Hans Kreipe, Matthias Christgen, Sherko Kümmel, Elisabeth Trapp, Rachel Wuerstlein, Andreas Hartkopf, Michael Clemens, Toralf Reimer, Lothar Häberle, Peter Andreas Fasching, Oleg Gluz, Nadia Harbeck
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C. British journal of cancer 126 (12) (2022)
Fabienne Schochter, Kim Werner, Cäcilia Köstler, Anke Faul, Marie Tzschaschel, Barbara Alberter, Volkmar Müller, Hans Neubauer, Tanja Fehm, Thomas W P Friedl, Bernhard Polzer, Wolfgang Janni, Brigitte Rack, Lisa Wiesmuller
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients. Cancers 12 (4) (2020)

Thomas W P Friedl.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas Friedl)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas W P Friedl (Thomas Friedl)